NASDAQ:CLOV Clover Health Investments (CLOV) Stock Price, News & Analysis $5.00 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$5.01 +0.01 (+0.30%) As of 06/18/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Clover Health Investments Stock (NASDAQ:CLOV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CLOV alerts:Sign Up Key Stats Today's Range$4.84▼$5.0350-Day Range$1.91▼$5.0052-Week Range$1.58▼$5.18Volume7.12 million shsAverage Volume9.07 million shsMarket Capitalization$2.63 billionP/E RatioN/ADividend YieldN/APrice Target$3.82Consensus RatingHold Company Overview Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members. At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams. This platform flags gaps in care, offers evidence-based treatment suggestions and facilitates member outreach to ensure adherence to preventive screenings and chronic condition management. Clover’s insurance products cover hospitalization, outpatient care, prescription drug benefits and various supplemental services, including telehealth and transportation assistance. Founded in 2014 by Vivek Garipalli and Kris Gale and headquartered in Jersey City, New Jersey, Clover Health has expanded its Medicare Advantage footprint across several U.S. states. The company serves beneficiaries in urban and rural markets, with operations spanning regions such as the Northeast, Southeast and Midwest. Under the leadership of its co-founders, Clover continues to invest in data science, artificial intelligence and member engagement tools to drive clinical quality improvements and cost efficiencies throughout its network.AI Generated. May Contain Errors. Read More Clover Health Investments Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks26th Percentile Overall ScoreCLOV MarketRank™: Clover Health Investments scored higher than 26% of companies evaluated by MarketBeat, and ranked 721st out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingHold Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 1 sell rating.Downside RiskClover Health Investments has a consensus price target of $3.82, representing about 23.7% downside from its current price of $5.00.Amount of Analyst CoverageClover Health Investments has only been the subject of 3 research reports in the past 90 days.Read more about Clover Health Investments' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is -41.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is -41.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 8.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Clover Health Investments' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.10% of the float of Clover Health Investments has been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 3.47, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Clover Health Investments has recently decreased by 23.52%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.20 News SentimentClover Health Investments has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Clover Health Investments this week, compared to 5 articles on an average week.Search InterestOnly 19 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.MarketBeat Follows6 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,534,679.00 in company stock.Percentage Held by Insiders23.51% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions19.77% of the stock of Clover Health Investments is held by institutions.Read more about Clover Health Investments' insider trading history. Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLOV Stock News HeadlinesClover Health Investments (NASDAQ:CLOV) VP Joseph Frank Oldakowski Sells 12,102 SharesJune 18 at 8:28 AM | insidertrades.comCramer's lightning round: Buy VistraJune 17 at 11:49 PM | cnbc.comThe AI agent that could reach every American by month's endJeff Brown picked Nvidia in 2016 - it's up 25,155%. He recommended Bitcoin at $240 - it's up 31,219%. Now he's zeroing in on Elon Musk's new AI agent, which Musk himself believes could return 70 times investors' money. Brown, who correctly predicted the SpaceX IPO and held Tesla when experts turned bearish, says an announcement is expected by end of month that could make this AI agent available to every American. He's offering a free live demo and ground-floor access details right now. | Brownstone Research (Ad)Clover Health Investments (NASDAQ:CLOV) Insider Karen Soares Sells 4,681 SharesJune 17 at 7:00 AM | insidertrades.comClover Health Stock Climbs on HHS Star Re-RatingJune 12, 2026 | marketwatch.comClover Health Investments (NASDAQ:CLOV) Shares Gap Up - Here's What HappenedJune 12, 2026 | americanbankingnews.comClover Health Investments (NASDAQ:CLOV) CEO Conrad Wai Sells 220,426 SharesMay 29, 2026 | insidertrades.comCarladenise Armbrister Edwards Sells 67,160 Shares of Clover Health Investments (NASDAQ:CLOV) StockMay 20, 2026 | insidertrades.comSee More Headlines CLOV Stock Analysis - Frequently Asked Questions How have CLOV shares performed this year? Clover Health Investments' stock was trading at $2.35 on January 1st, 2026. Since then, CLOV stock has increased by 112.8% and is now trading at $5.00. How were Clover Health Investments' earnings last quarter? Clover Health Investments, Corp. (NASDAQ:CLOV) issued its quarterly earnings results on Wednesday, May, 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.07 by $0.02. The firm earned $749.19 million during the quarter, compared to the consensus estimate of $714.89 million. Clover Health Investments had a negative trailing twelve-month return on equity of 16.52% and a negative net margin of 2.58%. Read the conference call transcript. Who are Clover Health Investments' major shareholders? Top institutional shareholders of Clover Health Investments include Dimensional Fund Advisors LP (0.65%), Renaissance Technologies LLC (0.65%), Bank of New York Mellon Corp (0.22%) and California State Teachers Retirement System (0.09%). Insiders that own company stock include Brady Patrick Priest, Karen Soares, Conrad Wai, Joseph Frank Oldakowski, Carladenise Armbrister Edwards and Anna U Loengard. View institutional ownership trends. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Clover Health Investments own? Based on aggregate information from My MarketBeat watchlists, some other companies that Clover Health Investments investors own include Zomedica (ZOM), AMC Entertainment (AMC), SoFi Technologies (SOFI), Jumia Technologies (JMIA), NIO (NIO), Meta Platforms (META) and NVIDIA (NVDA). Company Calendar Last Earnings5/06/2026Today6/19/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 CLOV's financial health is in the Green zone, according to TradeSmith. CLOV has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryInsurance Current SymbolNASDAQ:CLOV CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees680Year Founded2014Price Target and Rating Average Price Target for Clover Health Investments$3.82 High Price Target$4.75 Low Price Target$2.50 Potential Upside/Downside-23.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$85.55 million Net Margins-2.58% Pretax Margin-2.58% Return on Equity-16.52% Return on Assets-9.28% Debt Debt-to-Equity RatioN/A Current Ratio1.33 Quick Ratio1.33 Sales & Book Value Annual Sales$1.92 billion Price / Sales1.37 Cash FlowN/A Price / Cash FlowN/A Book Value$0.59 per share Price / Book8.47Miscellaneous Outstanding Shares526,680,000Free Float402,861,000Market Cap$2.63 billion OptionableOptionable Beta2.54 Social Links The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:CLOV) was last updated on 6/20/2026 by MarketBeat.com Staff. From Our PartnersBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredForget the million-dollar nest eggNearly 2 in 3 Americans fear running out of money more than death - and chasing a $1.5 million nest egg isn't ...Investors Alley | SponsoredElon Now Pays 15X More Than Your BankElon Musk's new bank is offering 6% interest per year - that's 15 times the national average of 0.4% that most...InvestorPlace | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredRead this before you touch SPCXSPCX is live on Nasdaq - but a market expert who called AMD before it climbed as high as 7,100% says buying th...Altimetry | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
